NCT03727737View on ClinicalTrials.gov

Efficacy of Repetitive Transcranial Magnetic Stimulation for Improvement of Memory in Older Adults With TBI

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

September 14, 2022

Study Completion Date

September 14, 2022

Conditions
Brain Injuries, TraumaticRepetitive Transcranial Magnetic StimulationMemory DeficitsAging
Interventions
DEVICE

Repetitive Transcranial magnetic Stimulation

RTMS will be delivered via magventure machine, on an approved FDA IDE protocol to DLPFC region to improve memory in older adults (veterans and non-veterans) with mild and moderate TBI.

Trial Locations (1)

94304

VA Palo Alto Health Care System, Palo Alto

All Listed Sponsors
collaborator

Stanford University

OTHER

collaborator

The Defense and Veterans Brain Injury Center

FED

lead

Palo Alto Veterans Institute for Research

OTHER

NCT03727737 - Efficacy of Repetitive Transcranial Magnetic Stimulation for Improvement of Memory in Older Adults With TBI | Biotech Hunter | Biotech Hunter